Hyderabad, June 14: Dr Reddy’s Laboratories Limited along with its subsidiaries together on Tuesday announced the launch of Dr Reddy’s Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar (sorafenib) Tablets in the US market following the approval by the US Food and Drug Administration (USFDA).
Speaking on the occasion, Dr Reddy’s Laboratories Inc, Chief Executive Officer, North America Generics, Marc Kikuchi said, ?We are pleased to launch this important generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients.?
Dr Reddy’s Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120, a company release here said. (UNI)
Follow our WhatsApp channel
